Items tagged with Global TB response

June 2022 issue of Public Health Action now online (post)

Public Health Action is the peer-reviewed open access journal of The International Union Against Tuberculosis and Lung Disease. It communicates and reports new knowledge across all relevant areas of operational research including: infection control, nutrition, TB, HIV, vaccines, smoking, COVID-19, microbial resistance and disease outbreaks.

Global TB Caucus: TB video series (post)

The Global TB Caucus released a three-part video series: shorter-form primers that can easily inform people on key topics in the discussion surrounding TB.

IJTLD July 2022 issue now online (post)

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

GSK announces £1 billion R&D investment over ten years to get ahead of infectious diseases in lower-income countries (post)

• New investment supports further innovation in malaria, tuberculosis, and HIV, with a new emphasis on Neglected Tropical Diseases and anti-microbial resistance
• GSK Global Health R&D Hubs are progressing more than 30 potential new vaccines and medicines, targeting 13 high-burden infectious diseases
• GSK will also maintain donations of albendazole until the elimination of lymphatic filariasis, and double production of its adjuvant for use in the RTS,S malaria vaccine
• New commitments support GSK’s ambition to positively impact the health of more than 2.5 billion people in the next ten years

23 June 2022, London UK: GSK plc (LSE/NYSE: GSK) announced today an investment of £1bn over ten years to accelerate research and development (R&D) dedicated to infectious diseases that disproportionately impact lower-income countries.

Not enough antibiotics in drug development – WHO’s latest ‘pipeline’ report (post)

The World Health Organization (WHO) has once more raised the red flag over the lack of new antibacterial treatments being developed to address the mounting threat of antimicrobial resistance (AMR).

Call for submissions: Best practices on the engagement of affected communities and civil society in ending TB (post)

The World Health Organization (WHO) Global TB Program launched a call for submissions of best practices on the engagement of affected communities and civil society to accelerate progress to end TB.

7-1-7: Improving our response to TB (post)

The Union and international partners are exploring whether the detection and control of tuberculosis (TB) can be improved using the “7-1-7” metric.

IJTLD August 2022 issue now online (post)

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

Global Fund reports significant progress in breaking down human rights-related barriers to HIV and TB services (post)

MONTREAL, 31 July 2022 – A new report [ download in English | Español | Français | Русский ] released by the Global Fund today at the 24th International AIDS Conference unveils key findings of the activities supported by the Global Fund’s Breaking Down Barriers initiative, a groundbreaking program launched in 2017 to provide intensive financial and technical support to 20 countries* to address stigma and discrimination, criminalization and other human rights-related obstacles that continue to threaten progress against HIV, tuberculosis (TB), and malaria.

Rich countries put billions into global COVID responses. Low-income countries wish they could spend it on bigger problems. (post)

Wealthy nations, including the United States, have treated the Covid-19 pandemic as a once-in-a-century threat to public health that necessitated an unprecedented response, both in sped-up vaccine development and counter-measures like lockdowns.